A β peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

Nature

Volumn 408, Issue 6815, 2000, Pages 982-985

  Morgan, Dave ^a   Diamond, David M ^b,c   Gottschall, Paul E ^a   Ugen, Kenneth E ^b   Dickey, Chad ^b   Hardy, John ^d   Duff, Karen ^e   Jantzen, Paul ^a   DiCarlo, Giovanni ^a   Wilcock, Donna ^a   Connor, Karen ^a   Hatcher, Jaime ^f   Hope, Caroline ^f   Gordon, Marcia ^a   Arendash, Gary W ^f  

^a Department of Pharmacology   (United States)

^b Department of Psychology ^*

^c James A Haley VA Center   (United States)

^d MAYO CLINIC   (United States)

^e NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN;

AGE; ALZHEIMER DISEASE; AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; COGNITION; CONTROLLED STUDY; LEARNING; MAZE TEST; MEMORY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRANSGENIC MOUSE; VACCINATION;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL LOBE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; SENILE PLAQUES; VACCINATION;

ANIMALIA; MUS MUSCULUS;

EID: 84984755327     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35050116     Document Type: Article

References (19)

1. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
2. Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice
3. Progressive behavioral impairments in transgenic mice carrying both mutant APP and PS1 transgenes
4. The importance of inflammatory mechanisms in Alzheimer disease
5. Inflammation and Alzheimer's disease pathogenesis
6. Microglial response to amyloid plaques in APPsw transgenic mice
7. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease
8. Neuron loss in APP transgenic mice
9. Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease
10. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
11. Modulation of Alzheimer's beta-amyloid neurotoxicity by site-directed single-chain antibody
12. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
13. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: Lack of association with amyloid deposits
14. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes
15. High level neuronal expression of Aβ1-42 in wild-type human amyloid precursor protein transgenic mice: Synaptotoxicity without plaque formation
16. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice
17. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1
18. Exposing rats to a predator impairs spatial working memory in the radial arm water maze
19. Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat